{
    "id": 32816,
    "fullName": "ABL1 L298V",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ABL1 L298V lies within the protein kinase domain of the Abl1 protein (UniProt.org). ABL1 L298V has been demonstrated to confer drug resistance in the context of BCR-ABL1 (PMID: 27868464), but has not been biochemically characterized and therefore, its effect on Abl1 protein function is unknown (PubMed, Mar 2020).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 18218,
                    "pubMedId": 27868464,
                    "title": "Imatinib resistance in chronic myeloid leukemia due to a rare mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27868464"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 25,
        "geneSymbol": "ABL1",
        "terms": [
            "ABL1",
            "ABL",
            "BCR-ABL",
            "bcr/abl",
            "c-ABL",
            "c-ABL1",
            "CHDSKM",
            "JTK7",
            "p150",
            "v-abl"
        ]
    },
    "variant": "L298V",
    "createDate": "03/17/2020",
    "updateDate": "03/17/2020",
    "referenceTranscriptCoordinates": {
        "id": 188522,
        "transcript": "NM_005157",
        "gDna": "chr9:g.130872198C>G",
        "cDna": "c.892C>G",
        "protein": "p.L298V",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20978,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Iclusig (ponatinib) inhibited survival of transformed cells expressing both ABL1 V299L and L298V in the context of BCR-ABL1 in culture (PMID: 28983061).",
            "molecularProfile": {
                "id": 35471,
                "profileName": "BCR - ABL1 ABL1 L298V ABL1 V299L"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 2531,
                "name": "hematologic cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 18128,
                    "pubMedId": 28983061,
                    "title": "BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28983061"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20973,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, ABL1 L298V was identified in a patient with Ph-positive (BCR-ABL1) chronic myeloid leukemia that was resistant to Gleevec (imatinib) treatment (PMID: 27868464).",
            "molecularProfile": {
                "id": 35472,
                "profileName": "BCR - ABL1 ABL1 L298V"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 8552,
                "name": "chronic myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 18218,
                    "pubMedId": 27868464,
                    "title": "Imatinib resistance in chronic myeloid leukemia due to a rare mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27868464"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 35470,
            "profileName": "ABL1 L298V",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 35471,
            "profileName": "BCR - ABL1 ABL1 L298V ABL1 V299L",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 35472,
            "profileName": "BCR - ABL1 ABL1 L298V",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 188522,
            "transcript": "NM_005157",
            "gDna": "chr9:g.130872198C>G",
            "cDna": "c.892C>G",
            "protein": "p.L298V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}